Our customized bioprocessing equipment portfolio delivers tailored, cGMP-compliant manufacturing solutions dedicated to full-spectrum vaccine production, covering viral vector cultivation, antigen expression, microbial fermentation, sterile formulation, and final purification workflows. Designed specifically for the highly stringent safety, sterility and reproducibility requirements of vaccine biomanufacturing, our customized systems eliminate process uncertainty and contamination risks, ensuring stable product quality across R&D, pilot scale-up and commercial mass production.
We provide fully personalized bioprocess equipment configuration based on diverse vaccine technical routes, including inactivated vaccines, mRNA vaccines, viral vector vaccines and recombinant protein vaccines. Customizable modules cover dedicated bioreactors, sterile media preparation systems, high-precision separation and clarification units, and closed formulation vessels. All equipment geometry, fluid characteristics, shear force control and process parameters are optimized to match fragile viral activity, sensitive cell culture and precise antigen production demands.
All product-contact components adopt high-grade 316L stainless steel with mirror-polished, dead-space-free structure, supporting full automatic CIP/SIP sterilization and fully closed sterile operation. Equipped with high-precision sensing, real-time parameter interlock and full data traceability functions, our customized equipment strictly complies with FDA, EMA and domestic vaccine manufacturing specifications, supporting complete process validation and regulatory audit requirements.
Featuring modular design and scalable architecture, our customized vaccine bioprocessing equipment allows flexible production switching, phased capacity expansion and iterative process upgrading. By minimizing manual intervention, reducing batch deviation and improving process stability, our tailored solutions help vaccine manufacturers shorten scale-up cycles, lower operational risks, and build reliable, high-efficiency and future-proof commercial vaccine production systems.
